| Title: | Darbepoietin-alfa has comparable erythropoietic stimulatory effects to recombinant erythropoietin whilst preserving the bone marrow microenvironment |
| Authors: | Dewamitta, SR Russell, MR Nandurkar, H Walkley, CR |
| Issue Year: | 2013 |
| Publisher | FERRATA STORTI FOUNDATION |
| Series | HAEMATOLOGICA: 98(5): 686-690 |
| Abstract | Erythropoiesis stimulating agents are widely used for the treatment of anemia. Recently, we reported erythroid expansion with impaired B lymphopoiesis and loss of trabecular bone in C57BL/6 mice following ten days of treatment with low-dose short acting recombinant human erythropoietin. We have assessed erythropoietin against longer-acting darbepoietin-alfa at a comparable erythroid stimulatory dosage regime. Darbepoietin-alfa and erythropoietin induced similar in vivo erythropoietic expansion. Both agents induced an expansion of the colony-forming unit-erythroid populations. However, unlike erythropoietin, darbepoietin-alfa did not impair bone marrow B lymphopoiesis. Strikingly the bone loss observed with erythropoietin was not apparent following darbepoietin-alfa treatment. This analysis demonstrates that whilst darbepoietin-alfa has similar in vivo erythropoietic potency to erythropoietin, it preserves the bone marrow microenvironment. Thus erythropoietin and darbepoietin-alfa manifest different action showing that erythropoiesis stimulating agents have differential non-erythroid effects dependent on their duration of action. |
| URI: | https://publications.svi.edu.au/publications/1678 |
| Other Identifiers | 10.3324/haematol.2012.078709 |
| Publication type | Article |
| Grant ID | GNT0559016; GNT1031481 |
| Find it online | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640110/pdf/0980686.pdf |